Clinical trials
ARDS (Moderate or Severe) clinical trials
Below are recruiting ards (moderate or severe) clinical trials, each written for real people, not researchers. We’re tracking 1,471 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06247397Recruiting
High-flow therapy for long-term oxygen users
This trial tests if adding high-flow oxygen therapy to your usual long-term oxygen therapy can help you breathe better. It is for people with COPD or ILD who use oxygen at home for at least 15 hours a day.
Karlskrona, Blekinge CountyAges 18 years+ - NCT07066826RecruitingPhase 2/Phase 3
Huperzine A for mild-to-moderate Alzheimer's dementia
This study tests whether Huperzine A controlled-release tablets can help improve memory and thinking in people with mild-to-moderate Alzheimer's disease. You'll take the tablets or a placebo to see if it slows down dementia symptoms.
BeijingAges 50–85 - NCT05333328RecruitingPhase 4
Test of ovarian function suppression for low-risk premenopausal node+ breast cancer
This trial studies whether ovarian function suppression (a treatment that lowers hormone production from the ovaries) helps women with hormone-receptor positive, HER2-negative breast cancer that has spread to lymph nodes, but who have a low-risk result on a genomic test. It may help reduce breast cancer recurrence while avoiding more intensive treatment for those who are lower risk.
Seoul, KoreaAges 20–50 - NCT07073378Recruiting
Brain-computer help for youth with severe disabilities
This study tests if a brain-computer interface (a device that reads brain signals) can help children and teens with severe physical or communication challenges do things at home, like moving a cursor or expressing themselves.
Calgary, AlbertaAges 5–18 - NCT06020495RecruitingPhase 3
DDAVP to prevent sodium overcorrection in severe low sodium
This trial tests a medication called DDAVP to prevent the sodium level from rising too quickly when treating severe low sodium in ICU patients. It is for those with dangerously low sodium and neurological symptoms, but without certain other medical conditions.
AmiensAges 18 years+ - NCT07060560Recruiting
Presepsin blood test for severe burn sepsis diagnosis
This study tests a blood test called presepsin to see how well it detects sepsis in people with severe burns. If you have burns covering at least 20% of your body and your doctor suspects sepsis, this trial may help improve early diagnosis and treatment.
Seoul, SeoulAges 18 years+ - NCT07063095RecruitingPhase 3
Testing two antibiotics combined for serious bacterial infections
This study tests whether combining two antibiotics (ceftazidime and fosfomycin) works better than ceftazidime alone for hospitalized adults with serious bacterial infections. If you have a severe infection thought to be caused by Gram-negative bacteria, this trial may offer a new treatment option.
Geneva, Canton of GenevaAges 18 years+ - NCT07057362Recruiting
Vitamin D and blood pressure during C-section under spinal anesthesia
This trial checks if low vitamin D levels can make a drop in blood pressure more likely or severe during a C-section with spinal anesthesia. It may help find ways to better monitor or prevent blood pressure problems during surgery.
Düzce, MerkezAges 18–40 - NCT07058896Recruiting
Improving walking skills in progressive multiple sclerosis
This study tests a program to help people with progressive multiple sclerosis who have severe walking difficulty. It aims to see if the program is feasible and can improve motor skills.
Ferrara, FEAges 18–75 - NCT07058155RecruitingPhase 4
TIPS and weight-loss surgery for liver disease with high blood pressure
This trial tests if doing a TIPS procedure (to lower blood pressure in the liver) before weight-loss surgery (sleeve gastrectomy) helps people with advanced liver disease. It's for those who have cirrhosis and very high blood pressure in the liver, and who qualify for sleeve gastrectomy.
Cleveland, OhioAges 18–70 - NCT05442710RecruitingPhase 2
Immune cell treatment for recovery from severe septic shock
This trial tests an immune-cell treatment given outside the body to help people recover from septic shock, a life-threatening reaction to infection. It aims to improve survival and organ recovery in patients who are still very ill despite standard care.
Freiburg im Breisgau, Baden-WurttembergAges 18 years+ - NCT06143072Recruiting
Care pathways for incontinence after childbirth injury
This study looks at the best ways to diagnose and treat accidental bowel leakage in women who had a tear during childbirth. It aims to improve care for women with this condition.
LondonAges 18–50 - NCT06231264Recruiting
Electrical acupressure for mild to moderate colitis
This trial tests whether a gentle electrical stimulation device (like acupuncture without needles) on the skin can help people with mild to moderate ulcerative colitis who haven't gotten better with standard treatments.
Xi'an, ShaanxiAges 18 years+ - NCT06437600Recruiting
Immediate balloon angioplasty for severe stroke with brain artery narrowing
This trial tests whether doing an angioplasty (a procedure to open a narrowed artery with a small balloon) as soon as possible after a severe stroke caused by a blockage in a brain artery can improve recovery. It is for people who arrive within 24 hours of their stroke and have a specific type of narrowing inside the skull.
Guangzhou, GuangdongAges 18 years+ - NCT07053800RecruitingPhase 2
Obe-cel for severe lupus with kidney inflammation
This trial tests a new cell therapy called obe-cel in people ages 12 to 65 with severe systemic lupus erythematosus (SLE) that has not responded to other treatments and has caused active lupus nephritis (kidney disease). The goal is to see if obe-cel can reduce lupus activity and improve kidney health.
New York, New YorkAges 12–65 - NCT07054060Recruiting
Surgery vs. Stenting for Recent Stroke Symptoms from a Narrowed Carotid Artery
This trial compares two procedures—surgery to remove plaque from a carotid artery or placing a stent to widen the artery—to see which is better for people who recently had warning signs or a small stroke due to a severe blockage. The goal is to find the safest and most effective way to prevent future strokes.
ParisAges 18 years+ - NCT07052409Enrolling by invitation
Protecting HIV-exposed infants from severe infections
This trial studies ways to protect babies who were exposed to HIV before birth but are not infected themselves. It aims to find better interventions to prevent severe infections in these infants.
JohannesburgAges 6 months–45 years - NCT07039916RecruitingPhase 3
Study of IMVT-1402 for mild to severe generalized myasthenia gravis
This trial tests an investigational drug called IMVT-1402 to see if it improves symptoms in people with generalized myasthenia gravis (gMG). If you have mild to severe gMG and are looking for new treatment options, this study may be a fit.
Huntsville, AlabamaAges 18–80 - NCT07039500Recruiting
Severe sleep apnea's impact on hearing and thinking
This study looks at how severe sleep apnea affects your brain's ability to process sounds and think clearly. You will have hearing tests and an EEG, which is a safe brainwave recording, to see if treating sleep apnea can help your hearing and thinking.
Beijing, Beijing MunicipalityAges 20–60 - NCT06710717RecruitingPhase 1
CD19 CAR T-cells for severe lupus
This early-phase trial tests whether a patient's own immune cells (T-cells) that are modified to target a protein called CD19 can help people with severe lupus that hasn't improved with other treatments. The goal is to reduce lupus activity and possibly achieve remission.
Bandar Tun Razak, Kuala LumpurAges 18–65 - NCT06720818Recruiting
Infection-fighting cells in severe lung injury
This study looks at a type of immune cell (MAIT cell) in patients with severe lung problems caused by infections, pancreatitis, head injury, burns, or major surgery. It aims to understand how these cells change during illness, which may lead to better treatments.
ToursAges 18 years+ - NCT07033741Recruiting
EMDR therapy for depression symptoms study
This trial studies whether EMDR therapy helps reduce depressive symptoms and what factors predict improvement. It is open to patients with anxiety, depression, PTSD, or dissociation symptoms.
Turin, TurinAges 18 years+ - NCT07025590Recruiting
Exercise to help lower antidepressants for heart patients
This trial tests whether adding a structured exercise program can help people with both depression/anxiety and heart disease slowly reduce their antidepressant medication. It may offer a way to lower medication use while improving heart and mental health.
Guangzhou, GuangdongAges 18–70 - NCT07025200Recruiting
Severe asthma study using bronchoscopy to check treatment
This study tests a new way to monitor severe asthma that is driven by high levels of inflammation (T2-high). It involves a bronchoscopy (a thin tube to look inside your lungs) to see how well the treatment is working.
Vienna, State of ViennaAges 18 years+
Hear when a new ARDS (Moderate or Severe) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ards (moderate or severe)?
- Yes. Clin2 currently lists 1,471 recruiting ards (moderate or severe) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ards (moderate or severe) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ards (moderate or severe) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.